CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 112 enrolled
Drug / intervention
multimodal:acetaminophen, gabapentin, ketamine, bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01868425
NCT01868425Phase 4Completed
CompareCT.gov

ACL Repair and Multimodal Analgesia

University of Wisconsin, Madison·interventional·Posted Jun 4, 2013·Updated Mar 30, 2020

In Brief

A Phase 4 clinical trial evaluating multimodal:acetaminophen, gabapentin, ketamine, bupivacaine and placebo pills and injectables for Pain. Completed, enrolled 112 participants across 1 site.

Detailed Summary

This study will evaluate the effectiveness of an aggressive multimodal regimen versus standard multimodal for Anterior Cruciate Ligament (ACL) repair using hamstring graft for patients having surgery in our outpatient surgicenter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 4, 2013
Enrollment StartApr 1, 2013
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 13.1 years ago

Interventions

multimodal:acetaminophen, gabapentin, ketamine, bupivacainedrug

acetaminophen, gabapentin, ketamine, bupivacaine and standard care which includes ketorolac, bupivacaine, fentanyl, ondansetron, dexamethasone, sevoflurane

placebo pills and injectablesdrug

receives standard care which includes ketorolac, bupivacaine, fentanyl, ondansetron, dexamethasone, sevoflurane plus placebos of intervention arm meds